FDA: For Immediate Release: Oct. 23, 2009
The U.S. Food and Drug Administration announced today that, in response to a request from the U.S. Centers for Disease Control and Prevention, it has issued an emergency use authorization (EUA) for the investigational antiviral drug peramivir intravenous (IV) in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are admitted to a hospital.
Weblink here
Quiz on new anti-influenza drugs on the HKSCCM web here
Homepage of BioCryst Pharmaceuticals here